Halbert Hargrove Global Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Halbert Hargrove Global Advisors's LLY Position: Q3 2026 in Review
Halbert Hargrove Global Advisors increased its Eli Lilly (LLY) stake by 0.84% in Q3 2026, buying an estimated $15.3K and bringing the position to 1,562 shares worth $1.81M. The position accounts for 0.08% of the portfolio, ranked #37.
Halbert Hargrove Global Advisors first reported a position in LLY in Q1 2015 and has held it in 30 quarters since. The position peaked at $1.94M in Q2 2024. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Halbert Hargrove Global Advisors held 1,562 shares of Eli Lilly worth $1.81M as of Q3 2026.
- Halbert Hargrove Global Advisors bought 13 Eli Lilly shares in Q3 2026, an estimated $15.3K.
- Eli Lilly made up 0.08% of Halbert Hargrove Global Advisors's portfolio in Q3 2026, its #37 holding.
- Halbert Hargrove Global Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 30 quarters since.
- Halbert Hargrove Global Advisors's Eli Lilly position peaked at $1.94M in Q2 2024.
- 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.